HEALTH

GlaxoSmithKline introduces ‘Nicorette Makes Quitting Suck Less’ ad campaign

BY Michael Johnsen

PITTSBURGH To help raise awareness around Commit Lozenge, which has been folded into the Nicorette franchise, GlaxoSmithKline earlier this week introduced a new commercial to its “Nicorette Makes Quitting Suck Less” campaign, the company announced Wednesday.

PITTSBURGH To help raise awareness around Commit Lozenge, which has been folded into the Nicorette franchise, GlaxoSmithKline earlier this week introduced a new commercial to its “Nicorette Makes Quitting Suck Less” campaign, the company announced Wednesday.

“Nicorette Makes Quitting Suck Less” was introduced in December 2009 as a frank-talk campaign using honest language and humorous situations to convey that the brand understands how hard it is to quit smoking, changing the way smoking-cessation brands communicate with smokers. The campaign has proven successful and is positively changing smokers’ perceptions of Nicorette, GlaxoSmithKline stated.

GlaxoSmithKline initially expanded its Nicorette portfolio beyond gum-based smoking-cessation solutions in March with the launch of Nicorette mint mini-lozenge.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Bazi International unveils energy shot

BY Michael Johnsen

DENVER Bazi International, formerly known as XELR8 Holdings, on Tuesday announced the official launch of its Bazi energy shot.

“Unlike other energy shots that overload the body with excessive caffeine, sugar, B vitamins, taurine and other artificial stimulants, Bazi combines nature’s finest ingredients for increased energy and better performance,” stated Kevin Sherman, the company’s president and CEO.

Bazi features a fruit-based formula that support long term health, increased energy and immunity support. The blend of superfruits includes jujube, blueberry, pomegranate, goji, mangosteen, raspberry, acai and seabuckthorn.

Bazi sells single shots at a suggested retail price of $2.99, and in packs of six and 12, at $17.99 and $28.99, respectively.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Perrigo gets FDA approval to manufacture milk-based infant formulas

BY Alaric DeArment

ALLEGAN, Mich. The Food and Drug Administration has given Perrigo the go-ahead to manufacture milk-based infant formulas through its partner, Saint-Claire, Quebec-based Kerry Proteins and Nutritionals, Perrigo said Wednesday.

The company received FDA clearance to market milk-based, ready-to-use and concentrate infant formulas with ARA and DHA in 8-oz. and 13-oz. bottles, and milk-based organic infant formula in 8-oz. bottles.

“We are excited to receive FDA clearance on these new liquid concentrate and ready-to-use products, and to expand our portfolio of nonpowder infant formula products,” Perrigo chairman and CEO Joseph Papa stated. “This is the first launch of new products since acquiring our infant nutrition business, and we look forward to further new product introductions.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES